Abstract
Metabolic reprogramming driven by folate restriction represents a therapeutic target for reducing the burden of breast cancer. Mol Cancer Res; 15(2); 189-200. ©2016 AACR.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have